A new workforce report on the United States pharmaceutical and biotechnology industry highlights strong growth in demand for skilled professionals, rising salaries across specialized roles, and a widening talent gap that could challenge industry expansion through 2025 and beyond. The analysis explores hiring trends, salary benchmarks, workforce challenges, and emerging skills shaping the future of the sector.
According to the report, the engineering workforce within the pharma and biotech industry is expected to grow by nearly 15% over the next five years. This growth is being driven by advances in biomanufacturing, production technologies, and process optimization. States such as North Carolina and Massachusetts are emerging as major engineering hubs, supported by strong university systems and increasing research investments.
Demand for data scientists and artificial intelligence specialists has also risen sharply. Over the past year, demand for these professionals has increased by more than 25% as companies rely more heavily on large datasets to support drug discovery, clinical research, and market analysis. Regions such as California and Massachusetts benefit from a strong supply of graduates due to the presence of leading universities and research institutions.
Cybersecurity is another rapidly growing area of demand. As pharmaceutical companies adopt digital systems for research, manufacturing, and data management, the need to protect sensitive information has become a priority. Job opportunities for cybersecurity professionals are expected to grow at an annual rate of about 20%. States including Maryland and Virginia are seeing increasing job postings due to their proximity to federal agencies and strong technology infrastructure.
Product management is also becoming a critical function in the sector. Companies are seeking experienced product managers to streamline development processes and bring new therapies to market more efficiently. However, the industry is expected to face a shortage of nearly 10,000 product managers by 2025, particularly in major biotech hubs such as California and Massachusetts.
The report indicates that universities across the United States produce roughly 50,000 graduates each year in fields related to life sciences, engineering, and data analytics. Despite this steady pipeline, demand for specialized professionals is expected to exceed supply by nearly 30%. As a result, the pharmaceutical and biotechnology sectors could face a total shortage of around 40,000 skilled professionals by 2025, with the largest gaps occurring in engineering and data analytics roles.
Hiring trends within the industry are also evolving. Approximately 60% of companies now support remote or hybrid work arrangements as a way to attract and retain talent, particularly in large metropolitan areas where the cost of living is high.
The report also highlights rising job vacancies across the industry. As of 2023, about 25% of open roles remained unfilled for more than six months, creating delays in research projects and operational challenges for companies. While universities continue to supply graduates, many employers report that candidates often lack the practical experience needed for specialized roles. As a result, companies are investing more heavily in training and professional development programs.
Salary benchmarking data shows strong growth in compensation across several high-demand roles. Entry-level data scientists earn an average salary of approximately $85,000, with senior professionals earning up to $130,000. Product managers command some of the highest salaries in the sector, with senior roles reaching around $140,000. Biotech engineers and cybersecurity analysts also earn competitive salaries, with senior professionals earning between $115,000 and $120,000 depending on experience and location.
Despite strong salary growth, companies continue to face workforce challenges. Annual employee turnover in the industry averages about 15%, creating disruption in projects that often require specialized knowledge and long development timelines. To address these challenges, organizations are focusing on stronger retention programs, career development opportunities, and improved workplace culture.
Looking toward 2030, the report identifies several new roles that will shape the future workforce in the life sciences industry. These include Data Science Analysts, Clinical Trial Managers, Biomanufacturing Engineers, Digital Health Strategists, Regulatory Affairs Specialists, and Supply Chain Resilience Officers. These roles will require a combination of technical knowledge, regulatory understanding, data analysis skills, and project management capabilities.
Automation is also expected to influence workforce dynamics. By 2030, nearly 40% of tasks across functions such as manufacturing, quality control, and data management could be automated. However, automation is expected to support employees rather than replace them entirely. Technologies such as artificial intelligence and robotics will help improve efficiency while allowing workers to focus on research, innovation, and complex decision-making.
The report also points to strong economic growth prospects for the sector. Healthcare spending and investment in innovative therapies are expected to drive industry expansion, with the broader life sciences economy projected to grow steadily through 2030. Government initiatives aimed at supporting medical innovation and research funding could generate more than 500,000 new jobs across the pharmaceutical and biotechnology industries.
Geographically, major biotech hubs such as Boston, San Francisco, and Raleigh-Durham continue to attract talent and investment. These cities benefit from strong research ecosystems, venture capital funding, and partnerships between industry and academia. At the same time, some regions are experiencing talent migration as professionals relocate to areas with stronger job opportunities and research activity.
Educational institutions remain a critical part of the talent pipeline. Universities such as the Massachusetts Institute of Technology, Stanford University, Johns Hopkins University, and the University of California, San Francisco continue to produce highly skilled graduates and contribute to research breakthroughs. In addition, specialized training programs and professional bootcamps are helping professionals gain skills in areas such as data analytics, regulatory affairs, and clinical research.
Large pharmaceutical companies including Pfizer, Johnson & Johnson, and Merck remain among the biggest employers in the sector, while innovative biotech firms such as Moderna and Amgen are increasing competition for skilled professionals. This competitive hiring environment is encouraging companies to invest more heavily in employer branding, career development, and workforce planning.
Overall, the report concludes that the U.S. pharmaceutical and biotechnology sector is entering a period of strong growth but also significant workforce challenges. Companies that invest in talent development, training programs, and flexible work models will be better positioned to address skill shortages and support long-term innovation in the industry.
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Tiếng Việt